Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▼ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Alkermes plc | 12 | 2 | 1 | 0 | €22.80 | €34.08 | 49.477% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €372.10 | €421.61 | 13.304% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | €11.60 | €22.78 | 96.339% |
| Ensign Group Inc. | 8 | 0 | 1 | 0 | €110.00 | €116.50 | 5.906% |
| United Therapeutics | 15 | 0 | 0 | 0 | €239.50 | €289.92 | 21.052% |
| Taro Pharmaceutical Industries Ltd | 7 | 0 | 1 | 0 | €39.40 | - | - |
| Merit Medical Systems | 16 | 0 | 5 | 0 | €69.50 | €86.90 | 25.032% |
| Select Medical Holdings | 3 | 0 | 1 | 0 | €26.00 | €36.41 | 40.025% |
| Haemonetics Corp. | 7 | 0 | 1 | 0 | €85.50 | €97.90 | 14.505% |
| Blueprint Medicines Corp | 1 | 0 | 1 | 0 | €87.72 | - | - |
| Integer Hldg | 1 | 0 | 0 | 0 | €104.00 | - | - |
| Amedisys Inc. | 13 | 0 | 0 | 0 | €84.50 | €92.26 | 9.183% |
| Icon plc | 18 | 0 | 6 | 0 | €279.10 | €318.99 | 14.294% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| LivaNova plc | 8 | 0 | 2 | 0 | €51.50 | €65.63 | 27.429% |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €91.00 | €124.85 | 37.195% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €18.70 | €31.74 | 69.727% |
| Bio-Techne Corp. | 8 | 0 | 0 | 0 | €60.50 | €75.80 | 25.289% |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €73.50 | €79.00 | 7.483% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €216.50 | €247.61 | 14.368% |
| Exelixis Inc. | 17 | 0 | 2 | 0 | €21.99 | €25.64 | 16.577% |
| Neurocrine Bioscience | 23 | 0 | 3 | 0 | €134.00 | €137.63 | 2.712% |
| Tenet Healthcare | 27 | 0 | 6 | 0 | €110.00 | €101.06 | -8.123% |
| Catalent Inc. | 2 | 0 | 0 | 0 | €52.32 | €55.00 | 5.122% |
| Bruker Corp. | 7 | 1 | 0 | 1 | €73.08 | €85.68 | 17.247% |